Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: The α-gal Syndrome - Investigating Immune Reactions to Tick Bites

View source ↗

Summary

A clinical trial update shows recruitment for a study on immune reactions to tick bites in Alpha-Gal Syndrome, sponsored by the Luxembourg Institute of Health.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Luxembourg Institute of Health | Conditions: Alpha-Gal Syndrome | Status: RECRUITING